thebench.bio #1 Ecosystem for the Bio-Tech Industry
All Molecular Biology questions

Question 20 of 20 Advanced Troubleshooting

A recombinant protein goes into inclusion bodies in E. coli. What would you change?

Short answer

Inclusion bodies form when protein is made faster than it can fold. Slow synthesis down with a lower temperature, weaker induction and a slower-growing culture, help folding with chaperones, a solubility tag or periplasmic export, and if those fail, purify the inclusion bodies and refold the protein in vitro.

Why

Rosano and Ceccarelli review why high-level expression in E. coli so often ends in aggregates. Folding intermediates expose hydrophobic surfaces, and at high concentration they find each other before they find their native state. Lowering the growth temperature to 15 to 25 C after induction slows synthesis more than folding and is the single most common fix.

Using less inducer, or a tunable system, has the same effect. Co-expressing chaperones gives the nascent chain more help. Fusion partners such as maltose-binding protein or thioredoxin often keep a protein soluble, though the tag must usually be cleaved later and the protein may aggregate once it is.

Proteins with disulfide bonds cannot fold properly in the reducing cytoplasm, so they are directed to the periplasm with a signal sequence or expressed in an engineered strain with an oxidizing cytoplasm. Rare codons can stall translation, which is handled by codon optimization or a strain supplying the rare tRNAs. Inclusion bodies are not always a defeat.

They are nearly pure protein and protected from proteases, so solubilization and refolding is a legitimate route, especially at scale.

How to work it through

  1. Confirm the protein really is in the pellet by running soluble and insoluble fractions side by side on a gel.
  2. Lower the post-induction temperature and reduce the inducer concentration, and extend expression time.
  3. Test a solubility tag and a chaperone co-expression plasmid in parallel small cultures.
  4. For disulfide-containing proteins, try periplasmic targeting or a strain with an oxidizing cytoplasm.
  5. Check for rare codons and switch strain or optimize the sequence if they cluster.
  6. If solubility stays low, scale the inclusion body route and screen refolding buffers by dilution or dialysis.

An example

A 45 kDa human enzyme is entirely insoluble at 37 C with 1 mM IPTG. Dropping to 18 C with 0.1 mM IPTG overnight moves about 20 percent into the soluble fraction. Adding a maltose-binding protein tag raises this to 70 percent, and the protein stays soluble after cleavage at 4 C.

Final yield is 8 mg per liter with specific activity matching the published enzyme.

Where the answer stops holding

Soluble does not mean correctly folded or active, so activity and a structural check such as size-exclusion chromatography are still needed. A tag can keep an unfolded protein in solution and mask the problem until it is removed. Refolding yields are often low and must be optimized per protein.

Some proteins need post-translational modifications that E. coli cannot make, and no expression tweak fixes that.

A strong answer covers

  • Aggregation follows synthesis outrunning folding
  • Lower temperature and weaker induction first
  • Chaperones and solubility tags
  • Periplasm or oxidizing strain for disulfide bonds
  • Refolding from inclusion bodies as a valid route

Common mistakes

  • Treating soluble expression as proof the protein is folded and active
  • Raising inducer concentration to get more protein
  • Keeping a solubility tag in the final product without testing the cleaved protein